Novacyt S.A. (EPA:ALNOV)
France flag France · Delayed Price · Currency is EUR
0.4590
-0.0089 (-1.90%)
May 15, 2025, 5:35 PM CET

Novacyt Company Description

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine.

The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases.

It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa.

The company was incorporated in 2006 and is based in Le Vésinet, France.

Novacyt S.A.
Novacyt logo
Country France
Founded 2006
Industry Medical Devices
Sector Healthcare
Employees 234
CEO Lyn Rees

Contact Details

Address:
131 Boulevard Carnot
Le Vésinet, 78110
France
Phone 33 1 39 46 51 04
Website novacyt.com

Stock Details

Ticker Symbol ALNOV
Exchange Euronext Paris
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency GBP
ISIN Number FR0010397232
SIC Code 2835

Key Executives

Name Position
Lyn Dafydd Rees Chief Executive Officer and Executive Director
Steve Gibson Chief Financial Officer and Director
Bryan Close Chief Operations Officer
Dr. Joanne Mason Chief Scientific Officer and Director
David Franks Chief Human Resources Officer
Paul Oladimeji Group Head of Research & Development